BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25603878)

  • 1. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.
    Khan K; Peckitt C; Sclafani F; Watkins D; Rao S; Starling N; Jain V; Trivedi S; Stanway S; Cunningham D; Chau I
    BMC Cancer; 2015 Jan; 15():15. PubMed ID: 25603878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
    Aydin D; Sendur MA; Kefeli U; Umut Unal O; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Bala Ustaalioglu B; Sener Dede D; Esbag O; Inal A; Bilir C; Bilici A; Harputlu H; Berk V; Sevinc A; Yildirim Ozdemir N; Yildirim E; Sonkaya A; Ali Ustaoglu M; Gumus M
    J BUON; 2016; 21(5):1242-1249. PubMed ID: 27837629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
    Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
    Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
    Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
    Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome.
    Hong SH; Koh YH; Rho SY; Byun JH; Oh ST; Im KW; Kim EK; Chang SK
    Jpn J Clin Oncol; 2009 Jan; 39(1):54-61. PubMed ID: 18997182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
    Overman MJ; Kopetz S; Wen S; Hoff PM; Fogelman D; Morris J; Abbruzzese JL; Ajani JA; Wolff RA
    Cancer; 2008 Oct; 113(8):2038-45. PubMed ID: 18759326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma.
    Li X; Ying H; Cheng Y; Zhao L; Zhao S; Bai C; Zhou J
    J BUON; 2019; 24(6):2539-2545. PubMed ID: 31983130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and prognostic factors for localised small bowel adenocarcinoma.
    Colina A; Hwang H; Wang H; Katz MHG; Sun R; Lee JE; Thomas J; Tzeng CW; Wolff RA; Raghav K; Overman MJ
    ESMO Open; 2020 Nov; 5(6):e000960. PubMed ID: 33188051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Treatment Strategies for Small Bowel Adenocarcinoma in Advanced-stage Cases.
    Nakanoko T; Koga T; Taketani K; Hirayama Y; Yoshiya S; Minagawa R; Kai M; Kajiyama K; Maehara Y
    Anticancer Res; 2015 Jul; 35(7):4135-8. PubMed ID: 26124367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic model to identify patients with advanced pancreas adenocarcinoma who could benefit from second-line chemotherapy.
    Kim ST; Choi YJ; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):105-11. PubMed ID: 21382702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China.
    Zhang L; Wang LY; Deng YM; Wang FH; Feng F; Chen YC; An X; Chen C; Xu RH; Li YH
    J BUON; 2011; 16(4):689-96. PubMed ID: 22331723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
    Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
    Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.
    Rompteaux P; Gagnière J; Gornet JM; Coriat R; Baumgaertner I; Lecomte T; Afchain P; Zaanan A; Pocard M; Bachet JB; Bonichon-Lamichhane N; Bouché O; Faucheron JL; Forestier J; Lecaille C; Manfredi S; Tougeron D; Terrebonne E; Chehimi M; Villing AL; Sarda C; Legoux JL; Benamouzig R; Aparicio T
    Eur J Surg Oncol; 2019 Mar; 45(3):331-335. PubMed ID: 30501999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.
    Moon YW; Rha SY; Shin SJ; Chang H; Shim HS; Roh JK
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):387-94. PubMed ID: 19760196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Small Bowel Adenocarcinoma.
    Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
    Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients.
    Aparicio T; Henriques J; Manfredi S; Tougeron D; Bouché O; Pezet D; Piessen G; Coriat R; Zaanan A; Legoux JL; Terrebone E; Pocard M; Gornet JM; Lecomte T; Lombard-Bohas C; Perrier H; Lecaille C; Lavau-Denes S; Vernerey D; Afchain P;
    Int J Cancer; 2020 Aug; 147(4):967-977. PubMed ID: 31912484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
    Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
    Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.
    Mountzios G; Bamias A; Voulgaris Z; Rodolakis A; Vlahos G; Gourgoulis G; Papaiakovou EE; Giannopoulos A
    Gynecol Oncol; 2008 Jan; 108(1):130-5. PubMed ID: 17988722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
    Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
    Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.